{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:02:30Z","timestamp":1779307350002,"version":"3.51.4"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The clinicopathologic spectrum of dedifferentiated, undifferentiated, and transdifferentiated melanoma occurring de novo or following systemic therapy is gaining recognition. Here, we present a patient with locally advanced cutaneous melanoma who received neoadjuvant anti-PD-1 therapy and whose post-treatment excisional pathology revealed transdifferentiation into a ganglioneuroblastic phenotype. This rare phenotype is hypothesized to be connected to melanoma's shared origin from pluripotent neural crest cells. This case report highlights the proposed pathogenic mechanisms underlying this transition after immune checkpoint therapy, including the pathways and factors that affect the tumor and its microenvironment.<\/jats:p>","DOI":"10.1097\/dad.0000000000003080","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:00:30Z","timestamp":1753722030000},"page":"e121-e124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Malignant Melanoma With Transdifferentiation Into a Ganglioneuroblastic Phenotype After Anti-PD-1 Therapy"],"prefix":"10.1097","volume":"47","author":[{"given":"Madison S.","family":"Harris","sequence":"first","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Castaneda","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Wieland","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Otolaryngology-Head & Neck Surgery, University of Wisconsin-Madison, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI;"},{"name":"Department of Dermatology, University of Wisconsin-Madison, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Birbrair","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Wisconsin-Madison, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliza","family":"Kapinski","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Albertini","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health, Madison, WI;"},{"name":"Department of Dermatology, University of Wisconsin-Madison, Madison, WI;"},{"name":"Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin-Madison, Madison, WI; and"},{"name":"The Medical Service, William S. Middleton Memorial Veterans Hospital, Madison, WI."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darya G.","family":"Buehler","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI;"},{"name":"Department of Dermatology, University of Wisconsin-Madison, Madison, WI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8417-2787","authenticated-orcid":false,"given":"Vincent T.","family":"Ma","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health, Madison, WI;"},{"name":"Department of Dermatology, University of Wisconsin-Madison, Madison, WI;"},{"name":"Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin-Madison, Madison, WI; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"R1-20250919","first-page":"118","article-title":"Great mimicker: a case of occult melanoma displaying ganglioneuroblastic differentiation","volume":"27","author":"Skrzypkowska","year":"2023","journal-title":"Contemp Oncol (Pozn)"},{"key":"R2-20250919","doi-asserted-by":"crossref","first-page":"102060","DOI":"10.1016\/j.ctrv.2020.102060","article-title":"Dedifferentiated melanomas: Morpho-phenotypic profile, genetic reprogramming and clinical implications","volume":"88","author":"Massi","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"R3-20250919","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/hmg\/ddl199","article-title":"Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma","volume":"15","author":"Ghiorzo","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R4-20250919","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.cell.2017.07.024","article-title":"Distinct cellular mechanisms underlie Anti-CTLA-4 and Anti-PD-1 checkpoint blockade","volume":"170","author":"Wei","year":"2017","journal-title":"Cell"},{"issue":"1","key":"R5-20250919","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1101\/gad.290940.116","article-title":"Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma","volume":"31","author":"Falletta","year":"2017","journal-title":"Genes Dev"},{"key":"R7-20250919","doi-asserted-by":"crossref","first-page":"e145859","DOI":"10.1172\/JCI145859","article-title":"Melanoma dedifferentiation induced by IFN-\u03b3 epigenetic remodeling in response to anti-PD-1 therapy","volume":"131","author":"Kim","year":"2021","journal-title":"J Clin Invest"},{"key":"R8-20250919","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","article-title":"A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma","volume":"187","author":"Pozniak","year":"2024","journal-title":"Cell"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T15:00:24Z","timestamp":1758294024000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003080","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]}}}